BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Tectonic Therapeutic readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Tectonic Therapeutic's drugs run\
 , from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06616974-542@assetmemo.bio
DTSTAMP:20261121T005644Z
DTSTART;VALUE=DATE:20261124
DTEND;VALUE=DATE:20261125
SUMMARY:Fc-relaxin fusion protein (TX45): Phase 2 readout est. (NCT06616974
 )
DESCRIPTION:Fc-relaxin fusion protein (TX45)\, phase 2\, Pulmonary Hyperten
 sion due to Left Heart Disease.\nStudy: A Study of TX000045 in Patients Wi
 th Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejecti
 on Fraction (the APEX Study)\nEstimated primary completion: 24 November 20
 26. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/fc-relaxin-fusion
 -protein-tx45#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT06616974
URL:https://assetmemo.bio/drug/fc-relaxin-fusion-protein-tx45#upcoming-even
 ts
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
